Search Results - "NAVASA, M"

Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation by Fondevila, C., Hessheimer, A. J., Flores, E., Ruiz, A., Mestres, N., Calatayud, D., Paredes, D., Rodríguez, C., Fuster, J., Navasa, M., Rimola, A., Taurá, P., García‐Valdecasas, J. C.

“…Maastricht type 2 donation after cardiac death (DCD) donors suffer sudden and unexpected cardiac arrest, typically outside the hospital; they have significant…”
Get full text

Liver Transplant Using Donors After Unexpected Cardiac Death: Novel Preservation Protocol and Acceptance Criteria by Fondevila, C., Hessheimer, A. J., Ruiz, A., Calatayud, D., Ferrer, J., Charco, R., Fuster, J., Navasa, M., Rimola, A., Taurá, P., Ginés, P., Manyalich, M., García‐Valdecasas, J. C.

“…Donors after cardiac death (DCD) suffer irreversible cardiac arrest prior to donation. We describe our liver transplant experience with DCD whose cardiac…”
Get full text

Donor and Recipient IL28B Polymorphisms in HCV‐Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation by Coto‐Llerena, M., Pérez‐del‐Pulgar, S., Crespo, G., Carrión, J. A., Martínez, S. M., Sánchez‐Tapias, J. M., Martorell, J., Navasa, M., Forns, X.

“…IL28B gene polymorphisms are associated with the response to antiviral therapy in hepatitis C patients. We investigated the influence of IL28B polymorphisms on…”
Get full text

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club by Wong, F, Bernardi, M, Balk, R, Christman, B, Moreau, R, Garcia-Tsao, G, Patch, D, Soriano, G, Hoefs, J, Navasa, M

“…Sepsis is a systemic inflammatory response to the presence of infection, mediated via the production of many cytokines, including tumour necrosis factor…”
Get full text

Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C by Crespo, G., Lens, S., Gambato, M., Carrión, J. A., Mariño, Z., Londoño, M.‐C., Miquel, R., Bosch, J., Navasa, M., Forns, X.

“…The value of transient elastography (TE) to assess clinical outcomes in hepatitis C recurrence after liver transplantation (LT) has not been explored so far…”
Get full text

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double‐Blind, Multicenter Controlled Trial by Winston, D. J., Saliba, F., Blumberg, E., Abouljoud, M., Garcia‐Diaz, J. B., Goss, J. A., Clough, L., Avery, R., Limaye, A. P., Ericzon, B. G., Navasa, M., Troisi, R. I., Chen, H., Villano, S. A., Uknis, M. E.

“…Maribavir is an oral benzimidazole riboside with potent in vitro activity against cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir…”
Get full text

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study by Millán, O, Rafael-Valdivia, L, San Segundo, D, Boix, F, Castro-Panete, M.J, López-Hoyos, M, Muro, M, Valero-Hervás, D, Rimola, A, Navasa, M, Muñoz, P, Miras, M, Andrés, A, Guirado, L, Pascual, J, Brunet, M

“…Abstract Acute rejection (AR) remains a major challenge in organ transplantation, and there is a need for predictive biomarkers. In the present multicenter…”
Get full text

Early Bacteremia After Solid Organ Transplantation by Linares, L, García-Goez, J.F, Cervera, C, Almela, M, Sanclemente, G, Cofán, F, Ricart, M.J, Navasa, M, Moreno, A

“…Abstract Objective Bloodstream infections (BSI) are a major cause of morbidity and mortality after solid organ transplantation. Our aim was to analyze early…”
Get full text

Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study by Benito, N., García-Vázquez, E., Horcajada, J.P., González, J., Oppenheimer, F., Cofán, F., Ricart, M.J., Rimola, A., Navasa, M., Rovira, M., Roig, E., Pérez-Villa, F., Cervera, C., Moreno, A.

“…There are no previous studies comparing tuberculosis in transplant recipients (TRs) with other hosts. We compared the characteristics and outcomes of…”
Get full text

Mannose‐Binding Lectin–Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection–Related Mortality After Liver Transplantation by Lombardo‐Quezada, J., Sanclemente, G., Colmenero, J., Español‐Rego, M., Arias, M. T., Ruiz, P., Mauro, E., Sastre, L., Crespo, G., Rimola, A., Moreno, A., Lozano, F., Navasa, M.

“…Mannose‐binding lectin (MBL) is synthesized by the liver and binds to microbes. MBL2 gene polymorphisms produce intermediate/low/null or normal MBL serum…”
Get full text

ATG‐Fresenius Treatment and Low‐Dose Tacrolimus: Results of a Randomized Controlled Trial in Liver Transplantation by Benítez, C. E., Puig‐Pey, I., López, M., Martínez‐Llordella, M., Lozano, J. J., Bohne, F., Londoño, M. C., García‐Valdecasas, J. C., Bruguera, M., Navasa, M., Rimola, A., Sánchez‐Fueyo, A.

“…We report the results of a prospective randomized controlled trial in liver transplantation assessing the efficacy and safety of antithymocyte globulin…”
Get full text

Cyclosporine A or Tacrolimus for Hepatitis C Recurrence? An Old Debate by Forns, X., Navasa, M.

“…Prospective studies analyzing the potential influence of cyclosporine A versus tacrolimus following liver transplant for hepatitis C virus on the new…”
Get full text

Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C by Martinez, S. M., Fernández‐Varo, G., González, P., Sampson, E., Bruguera, M., Navasa, M., Jiménez, W., Sánchez‐Tapias, J. M., Forns, X.

“…Aliment Pharmacol Ther 2011; 33: 138–148 Summary Background  Liver biopsy is the reference standard to assess liver fibrosis in chronic hepatitis C. Aim  To…”
Get full text

Liver Transplant From Unexpected Donation After Circulatory Determination of Death Donors: A Challenge in Perioperative Management by Blasi, A., Hessheimer, A. J., Beltrán, J., Pereira, A., Fernández, J., Balust, J., Martínez‐Palli, G., Fuster, J., Navasa, M., García‐Valdecasas, J. C., Taurá, P., Fondevila, C.

“…Unexpected donation after circulatory determination of death (uDCD) liver transplantation is a complex procedure, in particular when it comes to perioperative…”
Get full text

MiRNA 181a and 148a plasma levels during acute cellular rejection in liver transplantation by Ruiz, P, Millán, O, Orts, L, Aliart, I, Díaz, A, Sastre, L, Colmenero, J, Crespo, G, Brunet, M, Navasa, M

Get full text

Noninvasive assessment of liver fibrosis and portal hypertension after viral eradication in post-transplant hepatitis C by Mauro, E, Crespo, G, Londoño, M.C, Diaz, A, Ruiz, P, Sastre, L, Lombardo, J, Aguirre, J, Colmenero, J, Navasa, M

Get full text

Epidemiology and risk factors for late infection in solid organ transplant recipients by Cervera, C., Fernández-Ruiz, M., Valledor, A., Linares, L., Antón, A., Ángeles Marcos, M., Sanclemente, G., Hoyo, I., Cofán, F., Ricart, M.J., Pérez-Villa, F., Navasa, M., Pumarola, T., Moreno, A.

“…C. Cervera, M. Fernández‐Ruiz, A. Valledor, L. Linares, A. Antón, M. Ángeles Marcos, G. Sanclemente, I. Hoyo, F. Cofán, M.J. Ricart, F. Pérez‐Villa, M. Navasa,…”
Get full text

Restricted use of albumin for spontaneous bacterial peritonitis by Sigal, Samuel H, Stanca, Carmen M, Fernandez, Javier, Arroyo, Vicente, Navasa, Miguel

“…According to previous reports, 50% hospital mortality rate should have been expected. 2, 9 An explanation for the discriminative power of Cr and bili remains…”
Get full text

Influence of Cytomegalovirus Disease in Outcome of Solid Organ Transplant Patients by Linares, L, Sanclemente, G, Cervera, C, Hoyo, I, Cofán, F, Ricart, M.J, Pérez-Villa, F, Navasa, M, Marcos, M.A, Antón, A, Pumarola, T, Moreno, A

“…Abstract Introduction Despite recent advances in prevention and treatment, cytomegalovirus (CMV) is still a major complication in transplant patients. This…”
Get full text

Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation by Ramirez, S., Perez‐del‐Pulgar, S., Carrion, J. A., Costa, J., Gonzalez, P., Massaguer, A., Fondevila, C., Garcia‐Valdecasas, J. C., Navasa, M., Forns, X.

“…Hepatitis C virus (HCV) compartmentalization may have important implications in the pathogenesis of HCV infection. The aim of this study was to investigate the…”
Get full text